Prior to the current study, IRF5 expression within SLE CD4+ T cells had not yet been examined; however, in a previous study, we examined IRF5 activation via nuclear translocation by multispectral imaging flow cytometry and were unable to detect a difference between CD4+ T cells from healthy controls and SLE patients [34]. The gene discussed is CD4; the disease is systemic lupus erythematosus.